RZLT - Rezolute, Inc.

Insider Purchase by Evans Daron (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

6 days ago, Evans Daron, serving as CFO at Rezolute, Inc. (RZLT), purchased 10,000 shares at $2.85 per share, for a total transaction value of $28,500.00. Following this transaction, Evans Daron now holds 511,462 shares of RZLT.

This purchase represents a 2.00% increase in Evans Daron's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 30, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 1 day after the trade was made.

Rezolute, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Evans Daron

CFO

Daron Evans (age 52 as of September 2025) is the Chief Financial Officer at Rezolute, Inc. (Nasdaq: RZLT), appointed on January 23, 2024.[[1]](https://fintool.com/app/research/companies/RZLT/people/daron-evans)[[2]](https://ir.rezolutebio.com/news/detail/325/rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer)[[3]](https://rezolutebio.com/leadership/) He brings over 15 years of experience in financial operations, investor relations, and business development in public and private life science companies.[[2]](https://ir.rezolutebio.com/news/detail/325/rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer)[[6]](https://www.nasdaq.com/articles/rezolute-names-daron-evans-as-cfo) Evans holds a B.S. in Chemical Engineering from Rice University, an M.S. in Biomedical Engineering from the University of Texas at Arlington/UT Southwestern joint program, and an MBA from Duke University's Fuqua School of Business.[[1]](https://fintool.com/app/research/companies/RZLT/people/daron-evans)[[2]](https://ir.rezolutebio.com/news/detail/325/rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer)[[3]](https://rezolutebio.com/leadership/) His career highlights include serving as Chief Executive Officer of AlloRock, Inc. (cardiometabolic biotech), Specialty Renal Products, Inc. (dialysis devices), and Nephros, Inc. (medical devices), as well as CFO of Nile Therapeutics, Inc.[[1]](https://fintool.com/app/research/companies/RZLT/people/daron-evans)[[2]](https://ir.rezolutebio.com/news/detail/325/rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer)[[3]](https://rezolutebio.com/leadership/) Since 2015, he has been Managing Director of PoC Capital, LLC, focusing on public life sciences investments.[[1]](https://fintool.com/app/research/companies/RZLT/people/daron-evans)[[2]](https://ir.rezolutebio.com/news/detail/325/rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer)[[3]](https://rezolutebio.com/leadership/) As of recent data, he owns approximately 512,900 shares of RZLT stock.[[5]](https://www.gurufocus.com/insider/36424/daron-evans)

View full insider profile →

Trade Price

$2.85

Quantity

10,000

Total Value

$28,500.00

Shares Owned

511,462

Trade Date

Monday, March 30, 2026

6 days ago

SEC Filing Date

Tuesday, March 31, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Rezolute, Inc.

Company Overview

No company information available
View news mentioning RZLT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5255652

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime